Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

CoronaVac provides herd immunity in region of the Colombian Amazon

Researchers determine the effectiveness of the CoronaVac® vaccine in a Colombian Amazon population.

23 Jan 2022

SARS-CoV-2 Omicron associated with fewer lower and more upper respiratory tract symptoms

Researchers assess the impact of the SARS-CoV-2 Omicron variant of concern on symptoms of SARS-CoV-2 infection.

23 Jan 2022

Paxlovid provides a glimpse into the future against SARS-CoV-2

A recent study reveals that nirmatrelvir is potent and effective against the SARS-CoV-2 Omicron variant.

23 Jan 2022

Determining evolution of COVID-19 mortality rates using machine-learning

Researchers predict the evolution of COVID-19 mortality rates across countries using a biological science-guided machine learning-based approach.

23 Jan 2022

Impact of booster vaccines against SARS-CoV-2 Omicron variant

Researchers explore the dynamics of COVID-19 vaccine-induced protection against SARS-CoV-2 variants of concern.

23 Jan 2022

Omicron found to have higher environmental stability among SARS-CoV-2 variants

A new study compared the SARS-CoV-2 Wuhan strain and all the variants of concern (VOCs) - Alpha, Beta, Delta, and Omicron variants for their survivability and infectivity.

21 Jan 2022

Alphacoronaviruses found to be common in bats in the upper Midwestern United States

In a new study, researchers used a pan-coronavirus PCR to screen bats submitted for rabies testing owing to human exposure in order to find potentially novel bat CoVs that may represent a concern to people.

21 Jan 2022

Study shows monoclonal antibody and antiviral therapy are useful in preventing the severity of SARS-CoV-2 Omicron infection

In a new study, researchers assessed the efficacy of the FDA-approved therapeutic mAbs, as well as to small-molecule antiviral agents against the SARS-CoV-2 Omicron variant in Syrian hamsters.

21 Jan 2022

Study supports that Omicron variant has shifted to better usage of Cathepsin B/L entry pathway

A new study analyzed new data on the Omicron variant and indicated the altered cell entry pathways compared to other variants.

21 Jan 2022

Exploring the likelihood of SARS-CoV-2 becoming an endemic disease

Several deadly pandemics have emerged in human history that have either disappeared or turned into epidemics. Researchers explored the likelihood that SARS-CoV-2 would also eventually become an endemic disease.

21 Jan 2022

Prevalence and evolution of PTSD symptoms in cancer patients during COVID-19 pandemic

The focus of this study was to investigate the evolution of PTSD symptoms in cancer patients over the first year of the COVID19 pandemic.

21 Jan 2022

SARS-CoV-2 prevalence in bivalve mollusks from harvesting areas in Southern Italy

The goal of the current study was to collect data on the prevalence of SARS-CoV-2 in bivalve mollusks harvested in the Campania region using dd RT-PCR for the detection of low levels of virus in mollusk tissues.

21 Jan 2022

Study suggests SARS-CoV-2 Omicron variant spike mediated immune escape and tropism shift

A new study showed that the SARS-CoV-2 Omicron spike binds to its receptor with enhanced affinity and yet evades vaccine-elicited neutralizing antibodies and that a booster mRNA vaccine broadened the neutralization of Omicron.

21 Jan 2022

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

A recent study, currently available on bioRxiv* preprint server, shows that a novel protease inhibitor known as nirmatrelvir has potent activity against Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other variants evaluated in this paper – which supports its potential role in reducing the disease burden from coronavirus disease 2019 (COVID-19).

21 Jan 2022

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

In their recent study posted to the preprint server bioRxiv*, the researchers from China have shown that tuftsin, a natural phagocytosis-stimulating peptide, can effectively impair the binding of SARS-CoV-2 spike S1 subunit to ACE2 receptor in a dose-dependent manner and therefore can be considered a potential drug against SARS-CoV-2 infection.

20 Jan 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

CoronaVac provides herd immunity in region of the Colombian Amazon

SARS-CoV-2 Omicron associated with fewer lower and more upper respiratory tract symptoms

Paxlovid provides a glimpse into the future against SARS-CoV-2

Determining evolution of COVID-19 mortality rates using machine-learning

Impact of booster vaccines against SARS-CoV-2 Omicron variant

Omicron found to have higher environmental stability among SARS-CoV-2 variants

Alphacoronaviruses found to be common in bats in the upper Midwestern United States

Study shows monoclonal antibody and antiviral therapy are useful in preventing the severity of SARS-CoV-2 Omicron infection

Study supports that Omicron variant has shifted to better usage of Cathepsin B/L entry pathway

Exploring the likelihood of SARS-CoV-2 becoming an endemic disease

Prevalence and evolution of PTSD symptoms in cancer patients during COVID-19 pandemic

SARS-CoV-2 prevalence in bivalve mollusks from harvesting areas in Southern Italy

Study suggests SARS-CoV-2 Omicron variant spike mediated immune escape and tropism shift

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

Indian study suggests significant decrease in protection from vaccine or natural immunity against Omicron variant

Researchers explore furin inhibitors as a potential tool for treating COVID-19 infection

Scientists explore the possibility of Omicron ending the COVID-19 pandemic

RASCL: new analytic pipeline for investigating selective forces acting on viral genes in SARS-CoV-2 sequences

Determining COVID-19 vaccine effectiveness among health care workers in Wales

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in